___

• 1. Li Y, Go VL, Sarkar FH. The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas. 2015;44(1):1-10. 2. Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Pancreatic cancer: diagnosis and treatments. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(3):1375-84. 3. Stan SD, Singh SV, Brand RE. Chemoprevention strategies for pancreatic cancer. Nature reviews Gastroenterology & hepatology. 2010;7(6):347-56. 4. Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas. 2011;40(3):339-51. 5. Harris DM, Srihari P, Go VL. Pancreatic cancer prevention and the 2010 Dietary Guidelines for Americans. Pancreas. 2011;40(5):641-3. 6. Bidoli E, Pelucchi C, Zucchetto A, Negri E, Dal Maso L, Polesel J, et al. Fiber intake and pancreatic cancer risk: a case-control study. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2012;23(1):264-8. 7. Bao Y, Hu FB, Giovannucci EL, Wolpin BM, Stampfer MJ, Willett WC, et al. Nut consumption and risk of pancreatic cancer in women. British journal of cancer. 2013;109(11):2911-6. 8. Garrido-Laguna I, Hidalgo M. Pancreatic cancer: from state- of-the-art treatments to promising novel therapies. Nature reviews Clinical oncology. 2015;12(6):319-34. 9. Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, Rao CV. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Current medicinal chemistry. 2012;19(22):3701-13. www.kliniktipdergisi.com 5 10. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer cell. 2012;21(3):418-29. 11. Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus- Bertram L, Dean LT, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. Journal of the National Cancer Institute. 2013;105(18):1344-54. 12. Azvolinsky A. Cancer risk: the fat tissue-BMI-obesity connection. Journal of the National Cancer Institute. 2014;106(4):dju100. 13. Frossard JL, Lescuyer P, Pastor CM. Experimental evidence of obesity as a risk factor for severe acute pancreatitis. World journal of gastroenterology. 2009;15(42):5260-5. 14. Navina S, Acharya C, DeLany JP, Orlichenko LS, Baty CJ, Shiva SS, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Science translational medicine. 2011;3(107):107ra10. 15. Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Frontiers in physiology. 2013;4:415. 16. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27-42. 17. Gukovsky I, Li N, Todoric J, Gukovskaya A, Karin M. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1199-209 e4. 18. Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Disease models & mechanisms. 2013;6(6):1353-63. 19. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010;140(1):49-61. 20. Louie SM, Roberts LS, Mulvihill MM, Luo K, Nomura DK. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochimica et biophysica acta. 2013;1831(10):1566-72. 21. Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, et al. Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Molecular cancer therapeutics. 2011;10(3):427-36. 22. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjorge T, Concin H, et al. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19(9):2307-17. 23. Rebours V, Gaujoux S, d'Assignies G, Sauvanet A, Ruszniewski P, Levy P, et al. Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN). Clinical cancer research : an official journal of the American Association for Cancer Research. 2015;21(15):3522-8. 24. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Archives of internal medicine. 2010;170(9):791-802. 25. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. Jama. 2009;301(24):2553-62. 26. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. International journal of cancer Journal international du cancer. 2011;129(7):1708-17. 27. Hori M, Kitahashi T, Imai T, Ishigamori R, Takasu S, Mutoh M, et al. Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet. Pancreas. 2011;40(8):1234-40. 28. La Vecchia C. Association between Mediterranean dietary patterns and cancer risk. Nutrition reviews. 2009;67 Suppl 1:S126-9. 29. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. The Journal of nutrition. 2004;134(12 Suppl):3479S-85S. 30. Liu RH. Dietary bioactive compounds and their health implications. Journal of food science. 2013;78 Suppl 1:A18-25. 31. Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, et al. Combined Measurement of the Higgs Boson Mass in pp Collisions at sqrt[s]=7 and 8 TeV with the ATLAS and CMS Experiments. Physical review letters. 2015;114(19):191803. 32. Hasima N, Ozpolat B. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell death & disease. 2014;5:e1509. 33. Barreto SG, Neale RE. Vitamin D and pancreatic cancer. Cancer letters. 2015;368(1):1-6. 34. Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014;159(1):80-93.